SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001933414-24-000030
Filing Date
2024-06-17
Accepted
2024-06-17 16:31:47
Documents
2
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1718656287.html 3  
1 FORM 3 wk-form3_1718656287.xml 3 1659
2 EX-24 mineralys-poaxgold.htm EX-24 9906
  Complete submission text file 0001933414-24-000030.txt   13073
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MINERALYS THERAPEUTICS, INC. 150 N. RADNOR ROAD, SUITE F200 RADNOR PA 19087
Business Address
Gold Alexander M (Reporting) CIK: 0002026429 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41614 | Film No.: 241048732